Across TCGA pan-cancer cohorts, CFAP77 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CFAP77 data layer compared with 22 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher CFAP77 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CFAP77 expression acts as an unfavorable survival marker.

LIHC are the cancer types where CFAP77 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.159	0.561	.023	4	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CFAP77 tumor-vs-normal RNA expression · all CFAP77 data types